Envestnet Asset Management
SRNE

Envestnet Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Envestnet Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,872
Closed -$10.5K – 4174
2022
Q4 		$10.5K Buy
+11,872
New +$15.7K ﹤0.01% 3938
2020
Q1 		– Sell
-17,862
Closed -$60K – 3186
2019
Q4 		$60K Buy
17,862
+1,827
+11% +$4.36K ﹤0.01% 3033
2019
Q3 		$34K Sell
16,035
-1,404
-8% -$3.27K ﹤0.01% 3000
2019
Q2 		$47K Buy
17,439
+2,525
+17% +$9.09K ﹤0.01% 2992
2019
Q1 		$71K Buy
14,914
+4,316
+41% +$11.3K ﹤0.01% 2914
2018
Q4 		$25K Buy
+10,598
New +$34.6K ﹤0.01% 2828

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return